MODIFICATION
65 -- Plant Based Proteins - Questions and Answers #3
- Notice Date
- 10/12/2012
- Notice Type
- Modification/Amendment
- NAICS
- 325411
— Medicinal and Botanical Manufacturing
- Contracting Office
- Other Defense Agencies, Defense Advanced Research Projects Agency, Contracts Management Office, 675 North Randolph Street, Arlington, Virginia, 22203-2114, United States
- ZIP Code
- 22203-2114
- Solicitation Number
- HR0011-12-R-0006
- Archive Date
- 11/6/2012
- Point of Contact
- Susan Shean,
- E-Mail Address
-
susan.shean@darpa.mil
(susan.shean@darpa.mil)
- Small Business Set-Aside
- N/A
- Description
- Questions and Answers #3 Amendment 0001 HR0011-12-R-0006 dated 18 September 2012 The above numbered Combined Synopsis/Solicitation is amended as set forth below. The hour and date specified for receipt of Offers is not extended. Offeror must acknowledge receipt of this amendment on the copy of any offer submitted. Failure of your acknowledgement may result in rejection of your offer. In order to allow Offerors to include various types of award instruments in their proposal information for past performance and experience, Combined Synopsis/Solicitation HR0011-12-R-0006 is amended as follows for Factor 3 - Past Performance and Experience: (3) Past Performance and Experience The offeror shall provide past performance information pertaining to three (3) recent and relevant contracts/award instruments for the same or similar work. The offeror shall include contract/award instrument numbers, points of contact with telephone numbers and a description of the effort. The offeror shall provide Certificates of Analyses (CofA's) for its past performance references, if relevant. The offeror shall also provide details on: (a) how it adhered to contract/award instrument schedules, including meeting interim milestones, and provided on-time completion of deliverables; (b) how it provided reliable performance and deliverables that conformed to contract/award instrument requirements and standards of good workmanship; (c) how it was responsive to technical direction; (d) how it has relevant experience in protein processing of a specific product or different types of biological products (vaccines, enzymes, monoclonal antibodies, biologically active hormones and therapeutic proteins, etc) in the plant expression platform; and (e) how products were within the proposed budget. Past Performance and Experience (Factor 3) The extent to which the offeror adhered to contract/award instrument schedules, including meeting interim milestones and provided on-time completion of deliverables. The extent the offeror: provided reliable performance and deliverables that conformed to contract/award instrument requirements and standards of good workmanship, and was responsive to technical direction; has relevant experience in protein processing of a specific product or different types of biological products (vaccines, enzymes, monoclonal antibodies, biologically active hormones and therapeutic proteins, etc.) in the plant expression platform; and provided Certificates of Analyses (CofAs) for these past performances, if relevant. The extent to which the offeror demonstrated products were within proposed budget. (end of Summary of Changes)
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/ODA/DARPA/CMO/HR0011-12-R-0006/listing.html)
- Record
- SN02913278-W 20121014/121012234351-bc28cf17a09cfbafd011b615d88b4fc5 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |